The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Molecular Basis for ADP-induced Platelet Activation
Open accessAbstract
ADP is an important platelet agonist causing shape change from smooth discoid shape to spiculated spheres and platelet aggregation. However, the molecular mechanisms involved in ADP-induced platelet activation have not been elucidated. We demonstrated earlier the existence of two distinct ADP receptors on platelets, one coupled to phospholipase C, P2TPLC, and the other to inhibition of adenylyl cyclase, P2TAC (Daniel, J. L., Dangelmaier, C., Jin, J., Ashby, B., Smith, J. B., and Kunapuli, S. P. (1998) J. Biol. Chem. 273, 2024-2029), in addition to the previously described P2X1 receptor. Here we report the cloning of a cDNA clone encoding the P2Y1 receptor from a human platelet cDNA library by homology screening with radiolabeled P2Y1-P2Y6 receptor cDNAs. ADP or 2-methyl(thio)-ADP-induced intracellular calcium increases were inhibited by the P2Y1 receptor-specific antagonists, adenosine 3'-phosphate 5'-phosphosulfate (A3P5PS), adenosine 3'-phosphate 5'-phosphate (A3P5P), and adenosine 2'-phosphate 5'-phosphate (A2P5P), in a concentration-dependent manner, but not by ARL 66096 or alpha, beta-MeATP. A3P5PS, A3P5P, and A2P5P also inhibited the shape change of aspirinated platelets induced by 10 microM ADP or 3 microM 2-methyl-(thio)-ADP in a concentration-dependent manner, with complete inhibition occurring at 300 microM. On the other hand ARL 66096 (100 nM), a potent P2TAC antagonist and alpha, beta-methylene-ATP (40 microM), a P2X1 receptor agonist, had no effect on ADP-induced platelet shape change. On the contrary, ADP-induced inhibition of adenylyl cyclase was blocked by ARL 66096, but not by alpha, beta-MeATP or the P2Y1 receptor-specific antagonists, A3P5PS, A3P5P, or A2P5P. These results demonstrate the role of the P2Y1 receptor in ADP-induced platelet shape change and calcium mobilization and support the idea that several P2 receptors are involved in the regulation of different aspects of platelet stimulus-response coupling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shaw, G., & Kamen, R. (1986) · Cell · doi:10.1016/0092-8674(86)90341-7 · Cited by 4,012
Nomenclature and classification of purinoceptors.
Fredholm, B. B., Abbracchio, M. P., Burnstock, G., Daly, J. W., Harden, T. K., Jacobson, K. A., Leff, P., & Williams, M. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06782-1 · Cited by 1,585
Is there a basis for distinguishing two types of P2-purinoceptor?
Burnstock, G., & Kennedy, C. (1985) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(85)90001-1 · Cited by 1,365
Adenosine Diphosphate in Red Cells as a Factor in the Adhesiveness of Human Blood Platelets
GAARDER, A., JONSEN, J., LALAND, S., HELLEM, A., & OWREN, P. A. (1961) · Nature · doi:10.1038/192531a0 · Cited by 786
Molecular Basis for ADP-induced Platelet Activation
Daniel, J. L., Dangelmaier, C., Jin, J., Ashby, B., Smith, J. B., & Kunapuli, S. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.2024 · Cited by 441
Self-citationRNA regulatory elements mediate control of Drosophila body pattern by the posterior morphogen nanos
Wharton, R. P., & Struhl, G. (1991) · Cell · doi:10.1016/0092-8674(91)90368-9 · Cited by 386
Cis- acting sequences responsible for anterior localization of bicoid mRNA in Drosophila embryos
Macdonald, P. M., & Struhl, G. (1988) · Nature · doi:10.1038/336595a0 · Cited by 350
Towards a revised nomenclature for P1 and P2 receptors
Fredholm, B. B., Abbracchio, M. P., Burnstock, G., Dubyak, G. R., Harden, T. K., Jacobson, K. A., Schwabe, U., & Williams, M. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(96)01038-3 · Cited by 347
Ubiquitous expression of the 43- and 44-kDa forms of transcription factor USF in mammalian cells
Sirito, M., Lin, Q., Maity, T., & Sawadogo, M. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.3.427 · Cited by 320
Léon, C., Hechler, B., Vial, C., Leray, C., Cazenave, J.-P., & Gachet, C. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00022-7 · Cited by 296
Identification of competitive antagonists of the P2Y1 receptor.
Boyer, J. L., Romero-Avila, T., Schachter, J. B., & Harden, T. K. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09561-6 · Cited by 246
RASTINEJAD, F. (1993) · Cell · doi:10.1016/0092-8674(93)90579-f · Cited by 240
Daniel, J. L., Molish, I. R., Rigmaiden, M., & Stewart, G. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42774-8 · Cited by 216
Self-citationActivation of Receptor-operated Cation Channels via P2X1 Not P2T Purinoceptors in Human Platelets
MacKenzie, A. B., Mahaut-Smith, M. P., & Sage, S. O. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.6.2879 · Cited by 210
Cloning, Expression, and Chromosomal Localization of the Human Uridine Nucleotide Receptor Gene
Nguyen, T., Erb, L., Weisman, G. A., Marchese, A., Heng, H. H. Q., Garrad, R. C., George, S. R., Turner, J. T., & O'Dowd, B. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.52.30845 · Cited by 197
Macfarlane, D., & Mills, D. (1975) · Blood · doi:10.1182/blood.v46.3.309.309 · Cited by 180
Davis, I., & Ish‐Horowicz, D. (1991) · Cell · doi:10.1016/0092-8674(91)90366-7 · Cited by 153
Mills, D. C. B. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650674 · Cited by 150
Cloning and Chromosomal Localization of the Human P2Y1 Purinoceptor
Ayyanathan, K., Webbs, T. E., Sandhu, A. K., Athwal, R. S., Barnard, E. A., & Kunapuli, S. P. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0139 · Cited by 142
Self-citationBoyer, J. L., Zohn, I. E., Jacobson, K. A., & Harden, T. K. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb17034.x · Cited by 141
Molecular Cloning of a Novel P2 Purinoceptor from Human Erythroleukemia Cells
Akbar, G. K. M., Dasari, V. R., Webb, T. E., Ayyanathan, K., Pillarisetti, K., Sandhu, A. K., Athwal, R. S., Daniel, J. L., Ashby, B., Barnard, E. A., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.31.18363 · Cited by 136
Self-citationIdentification of 6H1 as a P2YPurinoceptor: P2Y5
Webb, T. E., Kaplan, M. G., & Barnard, E. A. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0189 · Cited by 128
Identification of a P2Y-purinergic receptor that inhibits adenylyl cyclase.
Boyer, J., Lazarowski, E. R., Chen, X. H., et al. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39516-9 · Cited by 118
Platelet receptor expression on three human megakaryoblast-like cell lines.
Vittet, D., Mathieu, M., Launay, J., & Chevillard, C. (1992) · PubMed · Cited by 27
Akbar, G. K. M., Mills, D. C. B., & Kunapuli, S. P. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6396 · Cited by 24
Self-citation
Cited by
Receptors for Purines and Pyrimidines
Burnstock, G., & Verkhratsky, A. (2012) · Purinergic Signalling and the Nervous System · doi:10.1007/978-3-642-28863-0_5 · Cited by 3,958
Receptors for Purines and Pyrimidines
Ralevic, V., & Burnstock, G. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01373-5 · Cited by 2,005
Abbracchio, M. P., Burnstock, G., Boeynaems, J.-M., Barnard, E. A., Boyer, J. L., Kennedy, C., Knight, G. E., Fumagalli, M., Gachet, C., Jacobson, K. A., et al. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.3 · Cited by 1,281
Arterial thrombosis—insidious, unpredictable and deadly
Jackson, S. P. (2011) · Nature Medicine · doi:10.1038/nm.2515 · Cited by 685
Enjyoji, K., Sévigny, J., Lin, Y., Frenette, P. S., Christie, P. D., Esch, J. S. A., Imai, M., Edelberg, J. M., Rayburn, H., Lech, M., et al. (1999) · Nature Medicine · doi:10.1038/12447 · Cited by 565
Metadata
- Authors
- Jin, J., Daniel, J. L., & Kunapuli, S. P.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1998-01
- Volume
- 273
- Issue
- 4
- Pages
- 2030-2034
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2030569295
- Cited by
- 477
- References
- 25
- FWCI
- 18.74
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.